An Open-Label Safety and Blood Collection Study in MnB rLP2086 Vaccinated Healthy Adult Volunteers for Immunological Assay Development.

Trial Profile

An Open-Label Safety and Blood Collection Study in MnB rLP2086 Vaccinated Healthy Adult Volunteers for Immunological Assay Development.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 22 Aug 2011

At a glance

  • Drugs PF 5212366 (Primary)
  • Indications Meningococcal group B infections
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Jul 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 01 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Dec 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top